Business · 22/08/2011Updated: 10/17/2026 · 1 min read
FDA Postpones Arthritis Advisory Committee Meeting
Summary
The FDA is postponing the Arthritis Advisory Committee meeting originally scheduled for September 13, 2011, due to new information from IND application holders for anti-nerve growth factor antibody drug products. This decision was announced in the Federal Register on July 19, 2011.
Original source language: Federal Register — Health and Human ServicesOpen original release →